Insulin-like growth factor-1 enhances β-amyloid protein clearance in HMC3 microglia via low-density lipoprotein receptor-related protein 1-mediated pathway

Key Points

• Beta-amyloid clearance significantly increases with insulin-like growth factor-1 treatment, showing promise for Alzheimer's therapies.
• This enhancement occurs through the low-density lipoprotein receptor-mediated pathway, indicating a specific mechanism involved.
• Analysis focused on HMC3 microglia, a model for studying Alzheimer's disease processes in human cells.
• Highlighting the role of insulin-like growth factor-1 may lead to new strategies for targeting amyloid accumulation in neurodegenerative diseases.